PQ 919
919. Deputy Eoin Hayes asked the Minister for Health the measures she is taking to uphold the commitment as outlined in the Programme for Government to ensure patients have timely access to new and innovative treatments, and in particular the drug named givinostat (brand name duvyzat), which is crucial for children with Duchenne muscular dystrophy; and if she will make a statement on the matter. [34523/25]
Introduced
24 June 2025
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
24 June 2025
Summary
919. Deputy Eoin Hayes asked the Minister for Health the measures she is taking to uphold the commitment as outlined in the Programme for Government to ensure patients have timely access to new and innovative treatments, and in particular the drug named givinostat (brand name duvyzat), which is crucial for children with Duchenne muscular dystrophy; and if she will make a statement on the matter. [34523/25]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Health Services
Health Services
xml · EN · 24 June 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2025-06-24/919/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2025-06-24/pq_919